Goldman Sachs’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $904K | Sell |
136,631
-25,781
| -16% | -$171K | ﹤0.01% | 3906 |
|
|
2025
Q1 | $1.49M | Buy |
162,412
+26,103
| +19% | +$239K | ﹤0.01% | 3555 |
|
|
2024
Q4 | $1.43M | Sell |
136,309
-25,964
| -16% | -$273K | ﹤0.01% | 3702 |
|
|
2024
Q3 | $1.94M | Buy |
162,273
+46,068
| +40% | +$551K | ﹤0.01% | 3391 |
|
|
2024
Q2 | $668K | Sell |
116,205
-98,124
| -46% | -$564K | ﹤0.01% | 3803 |
|
|
2024
Q1 | $1.11M | Buy |
214,329
+179,943
| +523% | +$936K | ﹤0.01% | 3552 |
|
|
2023
Q4 | $181K | Buy |
+34,386
| New | +$181K | ﹤0.01% | 4355 |
|
|
2023
Q3 | – | Sell |
-14,008
| Closed | -$40.5K | – | 4749 |
|
|
2023
Q2 | $40.5K | Buy |
14,008
+3,861
| +38% | +$11.2K | ﹤0.01% | 4691 |
|
|
2023
Q1 | $10.9K | Sell |
10,147
-29,090
| -74% | -$31.1K | ﹤0.01% | 4948 |
|
|
2022
Q4 | $102K | Sell |
39,237
-125,556
| -76% | -$328K | ﹤0.01% | 4670 |
|
|
2022
Q3 | $1.15M | Buy |
164,793
+108,130
| +191% | +$757K | ﹤0.01% | 3733 |
|
|
2022
Q2 | $386K | Buy |
56,663
+10,090
| +22% | +$68.7K | ﹤0.01% | 4550 |
|
|
2022
Q1 | $657K | Buy |
46,573
+5,538
| +13% | +$78.1K | ﹤0.01% | 4407 |
|
|
2021
Q4 | $594K | Buy |
+41,035
| New | +$594K | ﹤0.01% | 4404 |
|